Publications by authors named "Philip Greipp"

Claim this Profile
W
Waldenström macroglobulinemia: What a hematologist needs to know.
Prashant Kapoor, Jonas Paludo, Nishanth Vallumsetla, Philip R Greipp

Blood Rev· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Importance of achieving stringent complete response after autologous stem-cell transplantation in multiple myeloma.
Prashant Kapoor, Shaji K Kumar, Angela Dispenzieri, Martha Q Lacy, Francis Buadi, Philip R Greipp

J Clin Oncol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends and outcomes of modern staging of solitary plasmacytoma of bone.
Rahma Warsame, Morie A Gertz, Martha Q Lacy, Robert A Kyle, Francis Buadi, Philip R Greipp

Am J Hematol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular endothelial hyperpermeability induces the clinical symptoms of Clarkson disease (the systemic capillary leak syndrome).
Zhihui Xie, Chandra C Ghosh, Roshni Patel, Shoko Iwaki, Donna Gaskins, Philip R Greipp

Blood· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial.
Shaji K Kumar, Suzanne R Hayman, Francis K Buadi, Vivek Roy, Martha Q Lacy, Philip R Greipp

Blood· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements.
Shaji Kumar, Angela Dispenzieri, Martha Q Lacy, Suzanne R Hayman, Francis K Buadi, Philip R Greipp

J Clin Oncol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoglobulin D amyloidosis: a distinct entity.
Morie A Gertz, Francis K Buadi, Suzanne R Hayman, David Dingli, Angela Dispenzieri, Philip R Greipp

Blood· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Species D adenoviruses as oncolytics against B-cell cancers.
Christopher Y Chen, Julien S Senac, Eric A Weaver, Shannon M May, Diane F Jelinek, Philip Greipp

Clin Cancer Res· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of high-risk classification by FISH: an eastern cooperative oncology group (ECOG) study E4A03.
Susanna J Jacobus, Shaji Kumar, Hajime Uno, Scott A Van Wier, Greg J Ahmann, Philip R Greipp

Br J Haematol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac amyloidosis: a practical approach to diagnosis and management.
Prashant Kapoor, Thenappan Thenappan, Ekta Singh, Shaji Kumar, Philip R Greipp

Am J Med· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of gene expression profiling-based risk stratification in patients with myeloma receiving initial therapy with lenalidomide and dexamethasone.
Shaji K Kumar, Hajime Uno, Susanna J Jacobus, Scott A Van Wier, Greg J Ahmann, Philip R Greipp

Blood· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome.
Anita D'Souza, Suzanne R Hayman, Francis Buadi, Michelle Mauermann, Martha Q Lacy, Philip R Greipp

Blood· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease.
Martha Q Lacy, Jacob B Allred, Morie A Gertz, Suzanne R Hayman, Kristen Detweiler Short, Philip R Greipp

Blood· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction in plasma cell proliferation after initial therapy in newly diagnosed multiple myeloma measures treatment response and predicts improved survival.
Jeremy T Larsen, Cheng E Chee, John A Lust, Philip R Greipp, S Vincent Rajkumar

Blood· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: results from a phase 2 trial.
Shaji K Kumar, Martha Q Lacy, Suzanne R Hayman, Keith Stewart, Francis K Buadi, Philip R Greipp

Am J Hematol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myeloma.
Sumit Madan, Martha Q Lacy, Angela Dispenzieri, Morie A Gertz, Francis Buadi, Philip R Greipp

Blood· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature.
Sergio Siragusa, William Morice, Morie A Gertz, Robert A Kyle, Philip R Greipp

Ann Hematol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score.
Shaji K Kumar, Morie A Gertz, Martha Q Lacy, David Dingli, Suzanne R Hayman, Philip R Greipp

Mayo Clin Proc· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idiopathic systemic capillary leak syndrome (Clarkson's disease): the Mayo clinic experience.
Prashant Kapoor, Patricia T Greipp, Eric W Schaefer, Sumithra J Mandrekar, Arif H Kamal, Philip R Greipp

Mayo Clin Proc· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term results of single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myeloma.
Kristen Detweiler-Short, Suzanne Hayman, Morie A Gertz, Martha Q Lacy, Angela Dispenzieri, Philip R Greipp

Am J Hematol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma.
Francesca Gay, S Vincent Rajkumar, Morton Coleman, Shaji Kumar, Tomer Mark, Philip R Greipp

Am J Hematol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines.
Stephen M Ansell, Robert A Kyle, Craig B Reeder, Rafael Fonseca, Joseph R Mikhael, Philip R Greipp

Mayo Clin Proc· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Narrative review: the systemic capillary leak syndrome.
Kirk M Druey, Philip R Greipp

Ann Intern Med· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapie.
Prashant Kapoor, Rafael Fonseca, S Vincent Rajkumar, Shirshendu Sinha, Morie A Gertz, Philip R Greipp

Mayo Clin Proc· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma cell labeling index in the evaluation of smoldering (asymptomatic) multiple myeloma.
Sumit Madan, Robert A Kyle, Philip R Greipp

Mayo Clin Proc· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis